prednisone has been researched along with flucytosine in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (31.82) | 18.7374 |
1990's | 2 (9.09) | 18.2507 |
2000's | 6 (27.27) | 29.6817 |
2010's | 6 (27.27) | 24.3611 |
2020's | 1 (4.55) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Arlin, ZA; Clarkson, BD; Filippa, D; Gee, TS; Koziner, B; McKenzie, S; Mertelsmann, R; Moore, MA; Ralph, R | 1 |
Akrabawi, P; Elliott, JH; Gutow, GS; O'Day, DM; Podgorski, SF | 1 |
O'Morain, C | 1 |
Bottone, EJ; Hammer, GS; Hirschman, SZ | 1 |
Lally, EV; Spiegel, M; Zimmermann, B | 1 |
Barber, JC; Coats, M; Lawrence, L; Leveque, C; Schulman, JA | 1 |
Braverman, R; Cabreja, RF; Russell, RP; Watson, AJ; Whelton, A | 1 |
Brennan, M; Morgan, HJ | 1 |
Archer, J; Lane, M; McBride, J | 1 |
Behan, JW; Declerck, B; Kim, GH; Rodriguez, PG; Zhu, TH | 1 |
Jeng, A; Kalinoski, T; Malenfant, J; Yim, C | 1 |
1 review(s) available for prednisone and flucytosine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
21 other study(ies) available for prednisone and flucytosine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia.
Topics: Adult; Cell Separation; Female; Flucytosine; Humans; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Lymphocytes; Monocytes; Nucleotidyltransferases; Prednisone; Thioguanine; Vincristine | 1978 |
Mycotic endophthalmitis in drug abusers.
Topics: Administration, Oral; Administration, Topical; Adult; Amphetamines; Amphotericin B; Antifungal Agents; Aspergillosis; Candida; Candida albicans; Candidiasis; Clotrimazole; Endophthalmitis; Female; Flucytosine; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Prednisolone; Prednisone; Substance-Related Disorders | 1979 |
Elemental diets in the treatment of Crohn's disease.
Topics: Adolescent; Adult; Body Height; Body Weight; Child; Crohn Disease; Female; Flucytosine; Humans; Male; Middle Aged; Prednisone; Rifampin; Tetracycline | 1979 |
Mucormycosis in a transplant recipient.
Topics: Adult; Aged; Amphotericin B; Azathioprine; Brain Diseases; Drug Resistance, Microbial; Female; Flucytosine; Humans; Kidney Transplantation; Male; Middle Aged; Mucormycosis; Nose Diseases; Postoperative Complications; Prednisone; Transplantation, Homologous | 1975 |
Cryptococcal meningitis in systemic lupus erythematosus.
Topics: Adult; Amphotericin B; Cryptococcus; Female; Flucytosine; Humans; Lupus Erythematosus, Systemic; Meningitis, Cryptococcal; Prednisone | 1992 |
Fatal disseminated cryptococcosis following intraocular involvement.
Topics: Adult; Amphotericin B; Cryptococcosis; Flucytosine; Fundus Oculi; Humans; Male; Meningitis; Prednisone; Retina; Retinitis | 1988 |
Cure of cryptococcal infection during continued immunosuppressive therapy.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Immunosuppression Therapy; Kidney Transplantation; Prednisone | 1985 |
Exotic infection in the immunocompromised host.
Topics: Aged; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Immunosuppression Therapy; Male; Nephrotic Syndrome; Prednisone | 1986 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis.
Topics: Acetazolamide; Adult; Amphotericin B; Antifungal Agents; Arachnoiditis; Cerebral Infarction; Dexamethasone; Disease Progression; Drug Therapy, Combination; Fluconazole; Flucytosine; Headache; Humans; Hydrocephalus; Immunocompetence; Male; Meningitis, Cryptococcal; Prednisone; Ventriculoperitoneal Shunt | 2004 |
Cryptococcal cellulitis on the shin of an immunosuppressed patient.
Topics: Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Cyclosporine; Fluconazole; Flucytosine; Fungemia; Glomerulosclerosis, Focal Segmental; Humans; Immunocompromised Host; Immunosuppressive Agents; Leg Dermatoses; Male; Middle Aged; Prednisone; Skin | 2016 |
Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-Inflammatory Agents; Anti-Retroviral Agents; Antifungal Agents; Arachnoid; Arachnoiditis; Biopsy; Brain; Brain Abscess; Brain Edema; Cerebellar Diseases; Empyema, Subdural; Fluconazole; Flucytosine; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Prednisone; Recurrence | 2020 |